Retour sur lavenir.net
   RECTICEL 10.100 € (+1,00 %)     CMB.TECH 10.960 € (+1,67 %)     AB INBEV 64.460 € (+0,94 %)     KBC 116.950 € (+1,21 %)     DEME GROUP 184.400 € (+1,43 %)     SOLVAY 28.240 € (+0,79 %)     KINEPOLIS GROUP 29.450 € (+5,18 %)     ONTEX GROUP 2.950 € (+0,68 %)     SOFINA 225.000 € (+0,54 %)     BARCO 9.620 € (+1,96 %)     D'IETEREN GROUP 170.100 € (+1,01 %)     ONWARD MEDICAL 3.070 € (+0,99 %)     CARE PROPERTY INV. 12.800 € (+0,47 %)     UCB 273.550 € (-0,16 %)     IBA 13.820 € (+3,91 %)     AGEAS 67.800 € (+0,67 %)     FAGRON 23.050 € (+1,10 %)     TESSENDERLO 21.350 € (+0,47 %)     SHURGARD 27.750 € (+1,46 %)     AEDIFICA 73.600 € (+0,62 %)     RETAIL ESTATES 70.400 € (+0,28 %)     WDP 24.040 € (+1,01 %)     BIOTALYS 1.988 € (0,00 %)     ACKERMANS V.HAAREN 283.600 € (+1,00 %)     CAMPINE 225.000 € (+0,45 %)     MONTEA 70.000 € (+1,30 %)     SYENSQO 52.700 € (+1,35 %)     ARGENX SE 682.400 € (+0,80 %)     GBL 81.100 € (+0,50 %)     TITAN S.A. 49.620 € (+2,90 %)     KBC ANCORA 77.800 € (+0,78 %)     CENERGY 20.500 € (-0,87 %)     HYLORIS 5.080 € (+2,01 %)     AGFA-GEVAERT 0.490 € (0,00 %)     ELIA GROUP 135.000 € (-1,10 %)     XIOR 27.950 € (+0,90 %)     DECEUNINCK 2.155 € (+0,47 %)     EXMAR 9.820 € (-3,25 %)     PROXIMUS 6.990 € (+1,01 %)     TUBIZE-FIN 227.400 € (-0,18 %)     LOTUS BAKERIES 9 910.000 € (+1,12 %)     SEQUANA MEDICAL 0.498 € (+2,05 %)     COLRUYT 34.420 € (-0,81 %)     ASCENCIO 50.800 € (+0,79 %)     NYXOAH 2.410 € (+0,63 %)     AZELIS GROUP 9.565 € (+2,46 %)     EVS BROADC.EQUIPM. 35.450 € (+1,58 %)     BIOSENIC 0.002 € (0,00 %)     UMICORE 17.590 € (+0,92 %)     ECONOCOM GROUP 1.450 € (0,00 %)     BPOST 1.852 € (+0,98 %)     SIPEF 99.100 € (0,00 %)     GIMV 47.200 € (+0,53 %)     CIE BOIS SAUVAGE 327.000 € (0,00 %)     TINC 11.860 € (+0,34 %)     MELEXIS 57.750 € (+1,40 %)     BEKAERT 41.450 € (-0,12 %)     VIOHALCO 13.900 € (0,00 %)     CFE 11.250 € (-0,88 %)     OPTION 6.660 € (+9,18 %)  
   EMEIS 13.520 € (+0,37 %)     PULLUP ENTERTAIN 14.280 € (+2,73 %)     CVC CAPITAL 11.510 € (+0,09 %)     LOUIS HACHETTE 1.750 € (+0,75 %)     EXOSENS 63.300 € (+0,72 %)     FDJ UNITED 25.550 € (+0,47 %)     AYVENS 10.850 € (+1,78 %)     ERAMET 51.950 € (+2,67 %)     MINT 5.600 € (+0,72 %)     FERMENTALG 0.544 € (+0,93 %)     AIR LIQUIDE 187.900 € (+0,21 %)     MAGNUM 12.120 € (+0,98 %)     ASML HOLDING 1 289.600 € (+2,37 %)     2CRSI 40.340 € (+4,78 %)     TOTALENERGIES 79.700 € (+0,05 %)     L'OREAL 358.750 € (+0,55 %)     CREDIT AGRICOLE 17.180 € (+0,56 %)     VALLOUREC 23.540 € (-0,25 %)     LVMH 471.000 € (-2,23 %)     REXEL 37.230 € (+0,40 %)     CHRISTIAN DIOR 450.000 € (-2,17 %)     WALLIX 25.400 € (+4,10 %)     AXA 41.430 € (+0,41 %)     SHELL PLC 39.790 € (-0,24 %)     SOCIETE GENERALE 71.170 € (+0,98 %)     CAPITAL B 0.667 € (+7,03 %)     ARKEMA 61.850 € (+1,64 %)     AHOLD DEL 41.460 € (+0,46 %)     SCHNEIDER ELECTRIC 264.350 € (+1,56 %)     PERNOD RICARD 66.360 € (+1,62 %)     BOLLORE 4.936 € (+1,06 %)     ARCELORMITTAL SA 52.500 € (+1,59 %)     RIBER 11.700 € (+3,72 %)     VIRIDIEN 130.300 € (-0,84 %)     MICHELIN 30.820 € (+2,05 %)     DASSAULT SYSTEMES 17.595 € (+0,31 %)     AALBERTS NV 31.280 € (+1,30 %)     SENSORION 0.394 € (+5,50 %)     UNILEVER 49.715 € (+0,38 %)     ENGIE 28.960 € (-0,03 %)     CARREFOUR 16.540 € (+0,49 %)     VINCI 135.200 € (+0,52 %)     AEGON 6.850 € (+0,97 %)     INVENTIVA 4.440 € (+0,68 %)     CAPGEMINI 103.100 € (+0,63 %)     AKZO NOBEL 51.420 € (+1,62 %)     VALEO 11.185 € (+2,24 %)     SOITEC 71.360 € (+10,40 %)     BE SEMICONDUCTOR 217.400 € (+5,07 %)     EGIDE 1.094 € (+2,24 %)     ASM INTERNATIONAL 757.000 € (+1,99 %)     THALES 265.600 € (0,00 %)     ESSILORLUXOTTICA 198.900 € (+0,94 %)     BNP PARIBAS ACT.A 90.560 € (+0,88 %)     AIRBUS 172.200 € (+1,02 %)     J.MARTINS,SGPS 21.100 € (+1,25 %)     CARVOLIX 3.050 € (-1,61 %)     SPIE 47.220 € (+0,64 %)     VEOLIA ENVIRON. 34.830 € (+0,84 %)     AIR FRANCE -KLM 9.878 € (+2,49 %)  
News Réglementées
14/04/2026 07:00

AEVIS VICTORIA SA – Infracore SA – Ordinary General Meeting of Shareholders – All proposals approved

AEVIS VICTORIA SA / Key word(s): Miscellaneous
AEVIS VICTORIA SA – Infracore SA – Ordinary General Meeting of Shareholders – All proposals approved

14.04.2026 / 07:00 CET/CEST


Press release

Fribourg, 14 April 2026

Infracore SA – Ordinary General Meeting of Shareholders – All proposals approved

Infracore SA, Switzerland’s leading specialist in healthcare real estate, held its Ordinary General Meeting for the financial year 2025. All of the Board of Directors' proposals to the Annual General Meeting were approved. Martin Gafner, Antoine Hubert and Edward K. Aldag, Jr. were re-elected as Board members for a one-year term until the next Ordinary General Meeting. Dr. Stephan P. Thaler and Céline Amaudruz were elected as Board members, also for a one-year term. The proposed distribution of CHF 3.45 per share and participation certificate was also approved, confirming the Company’s stable distribution policy. It consists of a dividend of CHF 2.85 per share and participation certificate and a distribution of CHF 0.60 per share and participation certificate from the capital contribution reserves.

Board of Directors – Organization and Committees
Following the Annual General Meeting, the Board of Directors held its constitutive meeting and confirmed Martin Gafner as Chairman and Antoine Hubert as Vice-Chairman. The Board also established three standing committees to support its governance and oversight functions. The Audit and Compliance Committee will be chaired by Céline Amaudruz, with Antoine Hubert and Martin Gafner as members. The Nomination and Remuneration Committee will be chaired by Edward K. Aldag Jr., with Martin Gafner and Dr. Stephan P. Thaler serving as members. The Strategy and Investment Committee will be chaired by Antoine Hubert, with Edward K. Aldag, Jr. and Dr. Stephan P. Thaler as members.

2026 Outlook
Infracore maintains a positive outlook for the 2026 financial year. The guidance notably includes the integration of See-Spital in Horgen and anticipates growth in rental income as well as key financial metrics. The Company expects an increase in Funds From Operations (FFO) to more than CHF 48 million (2025: CHF 42.3 million) and a dividend in the range of CHF 45 million, corresponding to more than CHF 3.80 per share. These expectations reflect the strength of Infracore’s business model and the long-term value creation potential of its healthcare real estate portfolio.

For more information:  
Media and investor relations: c/o Dynamics Group, Zurich
Alexandre Müller, amu@dynamicsgroup.ch, +41 79 635 64 13

About Infracore SA
Infracore SA is a Swiss healthcare real estate company that owns, develops and manages hospital and clinic properties under long-term leases. Headquartered in Fribourg, the Group’s portfolio comprises 47 properties across 19 prime locations in Switzerland, totaling 221’157 sqm and a market value of CHF 1.41 billion. The assets are almost fully let under long-duration, inflation-indexed leases, predominantly to entities of Swiss Medical Network. Infracore generates recurring income from its stabilized portfolio and pursues growth through campus optimizations, extensions and selective developments, supported by a pipeline of about 42’053 sqm development potential. Infracore is jointly controlled by Medical Properties Trust, Inc. and AEVIS VICTORIA SA. www.infracore.ch.



End of Media Release
View original content: EQS News


2307436  14.04.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière